Adjunct Professor Resume Example

Driven and compassionate educator and health care professional with several years of hands-on experience in a major university and community college in addition, fast-paced residential and hospital environments. Accountable and responsible with a strong focus on education and student fulfillment. In addition to the above, several years of health care experience in face-paced and well respected teaching hospitals.

Goldberg MA, Bradstreet TE, McWilliams EJ, Tanaka WK, Lipert S, Bjornsson TD, Waldman SA, Osborne B, Pivadori L, Lewis G, and et al. "Biochemical Effects of Losartan, a Non-Peptide Angiotensin II Receptor Antagonist, on the Renin-Angiotensin-Aldosterone System in Hypertension Patients. Hyptertension 25 (1):37-46. Goldberg MA, Staub TL, Tanaka WK, Hilliard D, Lewis G, Bjornsson TD, Waldman SA, Osborne B, Pivadori L, Blum R, Herman T, Brown NJ, Abraham, PA, Halstensen CN, Katz SA, McWilliams EJ, Shadle CR, and Spector R. "Comparative Effects of Losartan, Hydrochlorothiazide, and Losartan/Hydrochlorothiazide on the Renin-Angiotensin-Aldosterone System in Hypertensive Patients. Hyptertension. Waldman S, Vitow C, Osborne B, Gillen L, Argenteri D, Wong F, Smith I, Chow A, Misiti J, and Bjornsson TD. "Kinetics and Dynamics of Tepoxalin After Single Oral Dose Administration to Healthy Volunteers. Journal of Clinical Pharmacology. Gharaibeh M, Gillen L, Osborne B, Schwartz J, and Waldman S. "Effect of Multiple Doses fo Rifampin on the 14C N-methyl] Erythromycin Breath Test in Healthy Male Volunteers." J of Clin Pharmacol. 38:(8):492-495. Greenberg H, Wissel P, Barrett R, Barchowsky A, Gould R, Farrell D, Panebianco B, Hand T, Gillen L, Goldberg M, and Bjornsson T. "Antiplatelet Effects of MK-852, A Platelet Fibrinogen Receptor Antagonist in Healthy Volunteers." ." J of Clin Pharmacol. 40:(5):496-507. Greenberg H, Gottesdiener K, Huntington M, Wong P, Wildonger L, Gillen L, Dorval E, Waldman S. "A New Cyclooxygenase-2 Inhibitor, Rofecoxib (Vioxx), Did Not Alter the Antiplatelet Effects of Lo-Dose Aspirin Healthy Volunteers." J of Clin Pharmacol. 40:(12):1509-1515. Greenber H, Tohatage S, Jensen B, Howard M, Boutouyrie B, Gillen L, Bjornsson T, Waldman S. "A Phase I, Double-Blind, Placebo- Controlled Tolerability, Pharmacokinetic and Pharmacodynamic Study of RPR 109891, a GP IIb/IIIa Platelet Antogonist, Administered as Repeated Oral Doses for 7 Days To Parallel Groups of Healthy Volunteers." Accepted for publication. Veronese M, Gillen L, Dorval E, Hauck W, Waldman S, Greenberg H, "Effect of Mibefradil on CYP3A4 in vivo" Accepted for publication by Clinical Pharmacology and Therapeutics. McCrea J, Prueksaritanont T, Gertz B, Carides A, Gillen L, Antonello S, Brucker M, Miller-Stein C, Osborne B, Waldman S. "Concurrent Administration of the Erythromycin Breath Test (EBT) and Oral Midazolam as InVivo Probes for CYP3A Activity." Accepted for publication by Journal of Clinical Pharmacology.